# 67457-445-60 · Rifampin Injection · Mylan Institutional, a Viatris Company — FDA drug shortage duration tracker For 67457-445-60 · Rifampin Injection · Mylan Institutional, a Viatris Company, package ndc is 67457-445-60; generic name is Rifampin Injection; manufacturer is Mylan Institutional, a Viatris Company; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-08. - **Package NDC:** 67457-445-60 _(verified: appears in the quote below)_ - **Generic name:** Rifampin Injection _(verified: appears in the quote below)_ - **Manufacturer:** Mylan Institutional, a Viatris Company _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Unavailable _(verified: appears in the quote below)_ - **FDA note:** Estimated recovery: Q4 2026 _(verified: appears in the quote below)_ - **Initial posting date:** 02/17/2021 _(verified: appears in the quote below)_ - **Last update date:** 08/20/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 2022 _(our reading, not quoted from the source)_ - **Reason for shortage:** Demand increase for the drug _(verified: appears in its own passage below)_ - **Dosage form:** Injection _(verified: appears in its own passage below)_ - **Therapeutic category:** Anti-Infective _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "02/17/2021", "package_ndc": "67457-445-60", "generic_name": "Rifampin Injection", "contact_info": "800-796-9526", "availability": "Unavailable", "related_info": "Estimated recovery: Q4 2026" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "08/20/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)", "company_name": "Mylan Institutional, a Viatris Company", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Status > "update_date": "08/20/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)", "company_name": "Mylan Institutional, a Viatris Company", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Last update date > "update_date": "08/20/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)", "company_name": "Mylan Institutional, a Viatris Company", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Reason for shortage > "update_date": "08/20/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)", "company_name": "Mylan Institutional, a Viatris Company", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Dosage form > "update_date": "08/20/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)", "company_name": "Mylan Institutional, a Viatris Company", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Therapeutic category > "update_date": "08/20/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Rifampin, Injection, 600 mg (NDC 67457-445-60)", "company_name": "Mylan Institutional, a Viatris Company", "shortage_reason": "Demand increase for the drug", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-08. Review by: 2026-09-11. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).